LDL-C

Merck’s Oral Cholesterol Drug Enlicitide Shows Positive Late-Stage Results

Merck’s Oral Cholesterol Drug Enlicitide Shows Positive Late-Stage Results

02 Sep 2025

1 min read

Daiichi Sankyo Europe Develops Fixed-Triple Oral Combination for LDL-C Reduction

Daiichi Sankyo Europe Develops Fixed-Triple Oral Combination for LDL-C Reduction

01 Sep 2025

1 min read

Novartis V-DIFFERENCE Study Shows Leqvio Helps 85% of Patients Reach LDL-C Targets

Novartis V-DIFFERENCE Study Shows Leqvio Helps 85% of Patients Reach LDL-C Targets

01 Sep 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com